Evidence method
Level · gp.fundamentals.capex_revenue_ratio
12.84% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
OVID · Mar 31, 2024
Ovid Therapeutics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-24-023067General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-11274.32% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
123.70% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-11768.24% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7025.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1329.73% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20255/6 normalizedLevel 3Jun 30, 20255/6 normalizedLevel 3Sep 30, 20255/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 10.29%
- Current
- 12.84%
- Delta
- 2.55%
- Previous
- -11687.90%
- Current
- -11274.32%
- Delta
- 413.58%
- Previous
- -73.93%
- Current
- 123.70%
- Delta
- 197.63%
- Previous
- -15134.60%
- Current
- -11768.24%
- Delta
- 3366.35%
- Previous
- 7298.51%
- Current
- 7025.00%
- Delta
- -273.51%
- Previous
- 1859.91%
- Current
- 1329.73%
- Delta
- -530.18%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · OVID Fundamental State →Has State · Ovid Therapeutics Inc. →Transitioned To · OVID Fundamental State →Transitioned To · OVID CAPEX_INTENSITY_INCREASED →Transitioned To · OVID CASH_GENERATION_INCREASED →Transitioned To · OVID GROWTH_INCREASED →Transitioned To · OVID PROFITABILITY_INCREASED →Transitioned To · OVID R_AND_D_INTENSITY_DECREASED →Transitioned To · OVID SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.